$3.99 USD Infusion Visit Protocol Start to Finish A comprehensive step-by-step protocol to guide healthcare providers through a safe and effective infusion visit from start to finish
The purpose of this study is to compare the risk of all-cause death and cardiovascular outcomes, including heart failure, in patients with type 2 diabetes treated with semaglutide versus dulaglutide in a real-world setting using TriNetX, a global healthcare data and analytics platform
In a controlled study measuring ad libitum eating (meaning participants could eat as much as they wanted), semaglutide reduced total energy intake by 24% across all meals throughout the day
Vegetarian capsules suitable for plant-based diets
Wondr Health launches industry-first advanced weight and obesity management solution with flexible cost-sharing options to control GLP-1 and total benefits spend For employers who want to improve employee access to safe, effective, branded GLP-1s at the lowest cost, Wondr Health now offers flexible program coverage optionsfrom 100% employee self-pay to limited or full coveragefor optimal cost control and choice
